A cost and resource utilization analysis of micafungin bridging for hemato‐oncological high‐risk patients undergoing allogeneic stem cell transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0609|94|6|526-531

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.94, Iss.6, 2015-06, pp. : 526-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Importance of Parenteral Nutrition in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

By  

Oncology Research and Treatment, Vol. 34, Iss. 4, 2011-03 ,pp. : 210-212

Karger

Access to resources Recommend Favorite

Platelet Antibodies and Fever: Their Association in Multitransfused Patients with Hemato-Oncological Diseases

By  

Transfusion Medicine and Hemotherapy, Vol. 26, Iss. 1, 1999-02 ,pp. : 34-36

Karger

Access to resources Recommend Favorite

The efficacy and safety of sirolimus‐based graft‐versus‐host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials

By  

TRANSFUSION, Vol. 41-1132, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy and safety of sirolimus‐based graft‐versus‐host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials

By  

TRANSFUSION, Vol. 55, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allogeneic Hematopoietic Stem Cell Transplantation in Mantle Cell Lymphoma: A Retrospective Analysis of 7 Patients

By  

Oncology, Vol. 89, Iss. 2, 2015-04 ,pp. : 118-123

Karger

Access to resources Recommend Favorite